LXRX FY 2015 Earnings — Lexicon Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

LXRXLexicon Pharmaceuticals, Inc.

$729M

FY 2015 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$130M+468.9% YoY

Gross Profit

$35M26.8% margin

Operating Income

$1M1.1% margin

Net Income

-$5M-3.6% margin

EPS (Diluted)

$-0.05

Cash Flow

Operating Cash Flow

$185M

Free Cash Flow

$184M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$655M

Total Liabilities

$369M

Stockholders' Equity

$286M

Cash & Equivalents

$521M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$130M	$23M	+468.9%
Gross Profit	$35M	-$66M	+152.4%
Operating Income	$1M	-$100M	+101.5%
Net Income	-$5M	-$100M	+95.3%